Navigation Links
QuantRx® Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments
Date:6/7/2012

areholders.

Additionally, we intend to separately secure financing for our women's health over the counter products business, to fund the commercial launch of our Unique™ and InSync™ products and to explore the potential acquisition of complementary products and companies to broaden our product offerings.

Dr. Shalom Hirschman, Chairman of the Board at QuantRx Biomedical, stated, "The Company's technologies and products offer innovative solutions for both feminine hygiene and fetal diagnostics. Our new QX Labs division enables management to provide each business opportunity with the specific resources, personnel, partners and capital necessary to drive success. Our ground breaking PadKit™ diagnostics technologies have the potential to define new standards of care and dramatically improve patient outcomes across a broad range of disease states including HPV detection, cancer testing, and adult and fetal genomics screening. It is a truly an exciting time to be involved with the Company and we believe separating the two businesses offers the most logical approach for funding the businesses and maximizing shareholder value."

About QuantRx Biomedical, Inc.  
QuantRx Biomedical Corporation (OTCBB: QTXB) is focused on the development and commercialization of genomic products for advanced diagnosis of serious disease and health conditions, and innovative over-the-counter miniform based products (uniqueminiform.com). With synergistic expertise in the discovery of diagnostic platforms leveraging a significant portfolio of intellectual property, QuantRx's mission is to introduce products for use by its medical laboratory, and consumers that deliver more accurate, reliable, and cost-effective diagnoses which result in improved patient care and a reduction in overall healthcare costs.

The QuantRx strategy targets significant market opportunities estimated to be in excess of $5 billion worldwide. The Company's te
'/>"/>

SOURCE QuantRx Biomedical Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Bunker Hill Community College Holds Biomedical Careers Graduation Ceremony
2. Fluke Biomedical training center goes global: adds multi-language support
3. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
4. Minority Biomedical Entrepreneurship Conference
5. ZyGEM to Provide its Unique DNA and RNA Extraction Technology to Middle East Biomedical Innovator Saudi Diagnostics Ltd.
6. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
7. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
8. Live Press Briefing on Findings of Biomedical Industry CEO Survey
9. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
10. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
11. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015  RegeneRx Biopharmaceuticals, Inc. ... in the scientific journal, Expert Opinion on Biological ... colleague, Dr. Zhenggang Zhang , at the Henry ... reported that Thymosin beta 4 (TB4) has the capacity ... 24 hours or more post-injury, leading to neurological recovery ...
(Date:3/3/2015)... New Jersey (PRWEB) March 03, 2015 ... has announced today that it has acquired The ... Terms of the transaction were not announced. , ... services to the energy sector including oil and ... energy, and fossil and nuclear power sectors. The ...
(Date:3/3/2015)... 03, 2015 Research and Markets ... Jain PharmaBiotech,s new report "Gene Therapy - ... , Gene therapy technologies are ... and cell therapy with genetically modified vectors. Gene ... and various routes of administration as well as ...
(Date:3/3/2015)... , March 3, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... sustainable chemicals, today announced it has initiated commissioning activities ... in Sarnia, Ontario , Canada.  ... approximately five months, with the facility being in commercial ... be completed in two months and it is carrying ...
Breaking Biology Technology:Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 2Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 3BioAmber Begins Commissioning of Sarnia Commercial Plant 2BioAmber Begins Commissioning of Sarnia Commercial Plant 3
... INDIANAPOLIS, March 7 Eli Lilly and Company,(NYSE: ... its AIR(R),Insulin program, which was being conducted in partnership ... clinical development as a potential,treatment for type 1 and ... not a result of any observations during AIR Insulin ...
... Kendle (Nasdaq: KNDL ), a,leading, global ... Executive Officer Candace Kendle, PharmD, and,President and Chief ... to sell shares of the company,s common stock ... part of their personal,ongoing long-term strategy for tax ...
... treatment ... disease, BIRMINGHAM, Ala., March 7 Atherotech, Inc., a,cardio-diagnostic ... in Booth 21041 at the American College of Cardiology,(ACC) 57th ... 1, 2008, at the McCormick Place Convention Center in,Chicago, Ill., ...
Cached Biology Technology:Lilly Announces Termination of AIR Insulin Program 2Lilly Announces Termination of AIR Insulin Program 3Lilly Announces Termination of AIR Insulin Program 4Kendle Leaders Adopt 10b5-1 Trading Plans 2Atherotech to Exhibit the VAP Test (R) at ACC 2008 Meeting in Chicago 2
(Date:3/2/2015)... VILNIUS, Lithuania , March 2, 2015   ... AI technologies, today introduced the SentiGaze Software Development ... developers to create applications that use off-the-shelf webcams to ... a user gazes at a monitor. Heatmaps can be ... determining the effectiveness of online advertising. The SDK can ...
(Date:2/23/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announced today ... DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND SYSTEM. ... payment method. Payment accounts may be selected via voice ... if both the speech (the word associated with the ...
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... filed provisional patent 62/113114 for DISTRIBUTED METHOD ... The patent further establishes NXT-ID,s position in ... intellectual property portfolio the ability for multiple devices to ...
Breaking Biology News(10 mins):Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3
... funded by the Office of Naval Research (ONR) were ... Engineers (PECASE), the nation,s highest honor for young scientists ... selection of these six individuals underscores ONR,s fundamental objective, ... by leveraging the ideas of the best and brightest ...
... is available in German . , ... more complex structures and better-adapted organisms. This is all ... Especially in small asexual populations that do not recombine ... known as Muller,s ratchet in evolutionary biology. The ratchet, ...
... scientists like it when the results of measurements fit with ... and compare their values, the results are rarely "smooth". A ... is: how much nitrogen is being fixed in the ocean ... is important to predicting future climate development. All organisms need ...
Cached Biology News:ONR-funded young innovators recognized by President 2Populations survive despite many deleterious mutations 2Populations survive despite many deleterious mutations 3How much nitrogen is fixed in the ocean? 2
Request Info...
Pancreatic Cell Cryopreservation Medium (2X) is intended for the cryopreservation of LT2 Immortalized Pancreatic Mesenchymal Cells (SCR013) and VIT1 Primary Pancreatic Mesenchymal Cells (SCR014)....
Rabbit polyclonal to Flagellin ( Abpromise for all tested applications). Antigen: Synthetic peptide from the flagellin C terminal domain of Burkholderia pseudomallei....
G-protein coupled purinergic receptor P2Y8...
Biology Products: